Celestica

CLS · NYSE · USD

$387.32Change from previous close: +3.81%Absolute change: +$14.23

Close · October 2, 2026

At a glance

Revenue growth
+28.46%
2025 vs 2024
Net income growth
+94.51%
2025 vs 2024
Net margin
6.7%
2024: 4.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total revenue4,6994,0473,6553,1942,893—
Cost of revenue4,1213,6103,2222,7782,522—
Gross profit578437433416371—
Selling, general and administrative58.111770.138.438.9—
Research and development46.341.230.236.434.0—
Operating income461268321330287—
EBIT463272314324272—
EBITDA507312367364317—
Interest expense21.216.012.612.814.4—
Pre-tax income442256301311257—
Income tax72.844.033.843.146.3—
Net income369212268268211—
Net income to common shareholders369212268268211—
Basic EPS3.211.852.332.331.83—
Diluted EPS3.211.832.312.311.82—
Average shares (basic)115115115115115—
Average shares (diluted)115116116116116—